Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
ADC ID |
DRG0MTUPD
|
|||||
---|---|---|---|---|---|---|
ADC Name |
CytSCA208
|
|||||
Synonyms |
Monoclonal antibody CA208-cytorhodin-S conjugate
Click to Show/Hide
|
|||||
Organization |
Aventis SA; Sanofi
|
|||||
Drug Status |
Clinical candidate
|
|||||
Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
|
|||||
Drug-to-Antibody Ratio |
15
|
|||||
Antibody Name |
CA208
|
Antibody Info | ||||
Antigen Name |
Pregnancy-specific beta-1-glycoprotein 2 (PSG2)
|
Antigen Info | ||||
Payload Name |
Cytorhodin S
|
Payload Info | ||||
Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
Linker Name |
Undisclosed
|
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.